BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp decreased its stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 21.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,068 shares of the medical instruments supplier’s stock after selling 26,071 shares during the quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in DENTSPLY SIRONA were worth $4,249,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in XRAY. Veritas Asset Management LLP boosted its stake in DENTSPLY SIRONA by 19.9% in the 2nd quarter. Veritas Asset Management LLP now owns 10,092,601 shares of the medical instruments supplier’s stock valued at $441,753,000 after buying an additional 1,674,946 shares in the last quarter. Thompson Siegel & Walmsley LLC boosted its stake in DENTSPLY SIRONA by 43.1% in the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 2,213,839 shares of the medical instruments supplier’s stock valued at $96,899,000 after buying an additional 667,148 shares in the last quarter. Mawer Investment Management Ltd. boosted its stake in DENTSPLY SIRONA by 185.6% in the 2nd quarter. Mawer Investment Management Ltd. now owns 734,943 shares of the medical instruments supplier’s stock valued at $32,168,000 after buying an additional 477,626 shares in the last quarter. Douglas Lane & Associates LLC boosted its stake in DENTSPLY SIRONA by 68.2% in the 2nd quarter. Douglas Lane & Associates LLC now owns 1,061,984 shares of the medical instruments supplier’s stock valued at $46,483,000 after buying an additional 430,599 shares in the last quarter. Finally, Anchor Capital Advisors LLC acquired a new stake in DENTSPLY SIRONA in the 2nd quarter valued at $18,620,000. 97.65% of the stock is currently owned by institutional investors and hedge funds.
XRAY has been the topic of several recent analyst reports. Zacks Investment Research lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Friday, May 11th. ValuEngine raised DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a research note on Wednesday, May 16th. Deutsche Bank decreased their price target on DENTSPLY SIRONA to $55.00 and set a “buy” rating on the stock in a research note on Wednesday, May 16th. Northcoast Research lowered DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a research note on Tuesday, June 5th. Finally, BidaskClub raised DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a research note on Wednesday, June 13th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $52.18.
DENTSPLY SIRONA stock opened at $39.46 on Thursday. The company has a current ratio of 1.69, a quick ratio of 1.10 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $8.88 billion, a price-to-earnings ratio of 14.83, a price-to-earnings-growth ratio of 2.31 and a beta of 1.21. DENTSPLY SIRONA Inc has a 52 week low of $37.70 and a 52 week high of $68.98.
DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Tuesday, August 7th. The medical instruments supplier reported $0.60 EPS for the quarter, topping analysts’ consensus estimates of $0.59 by $0.01. The company had revenue of $1.04 billion for the quarter, compared to analyst estimates of $1.03 billion. DENTSPLY SIRONA had a positive return on equity of 9.12% and a negative net margin of 39.62%. During the same quarter in the previous year, the firm earned $0.65 earnings per share. research analysts anticipate that DENTSPLY SIRONA Inc will post 2.07 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 12th. Shareholders of record on Friday, September 28th will be paid a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a yield of 0.89%. The ex-dividend date is Thursday, September 27th. DENTSPLY SIRONA’s dividend payout ratio is currently 13.16%.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Featured Story: How Do You Make Money With Penny Stocks?
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.